Biodesix announces third quarter 2021 results and highlights

Boulder, colo.--(business wire)---- $bdsx #patientsfirst--biodesix, inc. (nasdaq: bdsx), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced its financial and operating results for the third quarter ended september 30, 2021 and provided a corporate update. “the third quarter was highlighted by the growth of our core lung diagnostics and biopharma service product offerings, which grew year-over-year 51% and 133% respectively, despite the headwinds from the covid-19 delta vari
BDSX Ratings Summary
BDSX Quant Ranking